Viviana Di Fabio: The Synergy Between Hematology and Hemostasis Starts with Platelets
Viviana Di Fabio, Product Manager Marketing Hematology Global at Siemens Healthineers, shared a post on LinkedIn:
“The synergy between Hematology and Hemostasis starts with platelets.
Platelets are the natural bridge between these two disciplines, and a closer integration of Hematology and Hemostasis can help laboratories deliver more comprehensive and clinically valuable information for patient management.
At ISTH, we are showcasing how digital transformation can add value beyond a simple platelet count. Our digital morphology solution provides additional insights into platelet characteristics, morphology, distribution, and abnormalities, helping laboratorians gain a deeper understanding of platelet-related disorders and supporting more informed clinical decisions.
By combining advanced hematology analysis with hemostasis expertise, we can move from reporting results to delivering actionable clinical insights.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Jul 15, 2026, 06:35Wolfgang Miesbach: Paediatric Phase 3 BASIS KIDS Data for Marstacimab at ISTH 2026
-
Jul 15, 2026, 06:06Marija Tashkovska: Advancing Knowledge and Clinical Practice Through ISTH 2026
-
Jul 15, 2026, 05:55Hong Chow: Where Science Meets Art at ISTH 2026
-
Jul 15, 2026, 05:47Maria Magnusson: Advancing Hemostasis and Thrombosis Through Science and Collaboration at ISTH 2026
-
Jul 15, 2026, 05:32Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
-
Jul 15, 2026, 05:02Louise St. Germain Bannon: Scientific Collaboration at ISTH 2026
-
Jul 15, 2026, 04:41Heghine Khachatryan: Efgartigimod Shows Promising Results in iTTP
-
Jul 15, 2026, 04:30Sandeep Jagtap: Presenting the Research Behind Pediatric Fondaparinux at ISTH 2026
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study